Acelrx Pharmaceuticals (ACRX) Q4 2022 Earnings

30MarConfirmed
May 22
Aug 22
Nov 22
Q4 2022
-1.5
2.2
5.9
9.6

Details

Expected EPS
-0.51
Actual EPS
-1
Surprise EPS
-0.49
Surprise Percent
+96.08%

Description

Acelrx Pharmaceuticals (ACRX) has reported earnings of -1 per share for Q4 2022.

0 Comments

Share your thoughts